Final height of adults with childhood-onset steroid-responsive idiopathic nephrotic syndrome
Contribuinte(s) |
UNIVERSIDADE DE SÃO PAULO |
---|---|
Data(s) |
19/10/2012
19/10/2012
2009
|
Resumo |
The aim of this study was to evaluate the final stature of adults with childhood-onset steroid-responsive idiopathic nephrotic syndrome (INS) and the influence of disease-related issues on the achievement of their target heights. We analyzed 60 (41 male) patients and/or their records, with a minimum age of 19 years or at a Tanner`s pubertal stage 4 for boys or status postmenarche for girls, and normal glomerular filtration rate. Mean age at first and last consultation was 5.3 +/- 2.4 years and 20.5 +/- 3.1 years, respectively. Mean follow-up period was 15.10 years. Mean cumulative dose of prednisone was 1254 +/- 831.40 mg/kg. Mean initial and final height Z scores (HtZ) were, respectively, -0.60 +/- 1.0 and -0.64 +/- 0.92 (p = 0.72). The final HtZ showed a significant correlation only with the initial HtZ and the target HtZ (THZ). Six patients achieved a final HtZ below -2, which in male patients correlated strongly to the initial HtZ and THZ. A strong correlation was demonstrated between final HtZ, initial HtZ, and THZ. INS-related issues did not prevent the final stature to reach the predicted target height. |
Identificador |
PEDIATRIC NEPHROLOGY, v.24, n.12, p.2401-2408, 2009 0931-041X http://producao.usp.br/handle/BDPI/23180 10.1007/s00467-009-1301-z |
Idioma(s) |
eng |
Publicador |
SPRINGER |
Relação |
Pediatric Nephrology |
Direitos |
restrictedAccess Copyright SPRINGER |
Palavras-Chave | #Nephrotic syndrome #Growth #Final height #Glucocorticoid #Children #Adolescent #CATCH-UP GROWTH #HORMONE-RELEASING-HORMONE #CORTICOSTEROID TREATMENT #CHILDREN #PREDNISONE #SECRETION #THERAPY #PLATE #Pediatrics #Urology & Nephrology |
Tipo |
article original article publishedVersion |